ONCSQ (OncoSec Medical) Institutional Ownership: 0.00% (As of Jul. 08, 2026)


What is OncoSec Medical Institutional Ownership?

OncoSec Medical ONCSQ -99.00% Institutional Ownership is 0.00% as of Jul. 08, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OncoSec Medical's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OncoSec Medical's Insider Ownership is 44.34%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OncoSec Medical's Float Percentage Of Total Shares Outstanding is 87.20%.

OncoSec Medical Institutional Ownership Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Institutional Ownership Chart

OncoSec Medical Historical Data

The historical data trend for OncoSec Medical can be seen below:

2022-08-31 2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31
Institutional Ownership 4.27 4.23 4.31 4.28 0.66 0.66 0.64 0.58 0.38 0.28

OncoSec Medical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
OncoSec Medical (ONCSQ) has a Institutional Ownership of 0.00% as of Jul. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Institutional Ownership too high?
OncoSec Medical's current Institutional Ownership is 0.00%.
How does OncoSec Medical's Institutional Ownership compare to NOVNQ and USRM?
OncoSec Medical's Institutional Ownership of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Institutional Ownership of 0.00%. The current Institutional Ownership is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Institutional Ownership is 0.00% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.